End-of-day quote
BURSA MALAYSIA
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
3.3
MYR
|
-0.30%
|
|
+8.91%
|
+32.53%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,057
|
1,682
|
1,281
|
1,681
|
1,789
|
2,371
|
-
|
-
|
Enterprise Value (EV)
1 |
1,057
|
1,575
|
1,102
|
1,523
|
1,416
|
2,165
|
2,151
|
2,125
|
P/E ratio
|
20.1
x
|
30
x
|
21.5
x
|
16.5
x
|
4.47
x
|
24.9
x
|
22.6
x
|
21.2
x
|
Yield
|
1.54%
|
1.27%
|
2.04%
|
1.85%
|
2.01%
|
1.74%
|
2.08%
|
2.05%
|
Capitalization / Revenue
|
1.53
x
|
2.41
x
|
1.66
x
|
1.92
x
|
1.91
x
|
2.37
x
|
2.23
x
|
2.06
x
|
EV / Revenue
|
1.53
x
|
2.25
x
|
1.43
x
|
1.73
x
|
1.51
x
|
2.17
x
|
2.03
x
|
1.84
x
|
EV / EBITDA
|
13.5
x
|
20.1
x
|
12.9
x
|
14.1
x
|
13.4
x
|
18.7
x
|
17.2
x
|
16.5
x
|
EV / FCF
|
20.1
x
|
22.6
x
|
-
|
-
|
38.8
x
|
31.9
x
|
32.9
x
|
-
|
FCF Yield
|
4.97%
|
4.42%
|
-
|
-
|
2.58%
|
3.13%
|
3.04%
|
-
|
Price to Book
|
2.48
x
|
3.58
x
|
2.51
x
|
2.98
x
|
1.93
x
|
2.66
x
|
2.5
x
|
2.28
x
|
Nbr of stocks (in thousands)
|
707,812
|
712,634
|
714,374
|
716,374
|
718,375
|
718,606
|
-
|
-
|
Reference price
2 |
1.493
|
2.360
|
1.793
|
2.347
|
2.490
|
3.300
|
3.300
|
3.300
|
Announcement Date
|
2/19/20
|
2/25/21
|
2/23/22
|
2/22/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
688.8
|
698.7
|
770.8
|
877.7
|
936.2
|
999.1
|
1,061
|
1,152
|
EBITDA
1 |
78.31
|
78.17
|
85.51
|
108
|
105.5
|
115.9
|
125
|
128.9
|
EBIT
1 |
60.62
|
62.66
|
69.18
|
91.55
|
87.48
|
97.1
|
110.2
|
122
|
Operating Margin
|
8.8%
|
8.97%
|
8.98%
|
10.43%
|
9.34%
|
9.72%
|
10.39%
|
10.59%
|
Earnings before Tax (EBT)
1 |
66.33
|
70.17
|
75.41
|
120.4
|
423.3
|
114.6
|
126.3
|
133.8
|
Net income
1 |
52.75
|
56.02
|
59.42
|
101
|
398
|
95.34
|
105.4
|
111.4
|
Net margin
|
7.66%
|
8.02%
|
7.71%
|
11.5%
|
42.51%
|
9.54%
|
9.93%
|
9.67%
|
EPS
2 |
0.0743
|
0.0787
|
0.0835
|
0.1418
|
0.5565
|
0.1324
|
0.1460
|
0.1555
|
Free Cash Flow
1 |
52.52
|
69.57
|
-
|
-
|
36.5
|
67.8
|
65.3
|
-
|
FCF margin
|
7.62%
|
9.96%
|
-
|
-
|
3.9%
|
6.79%
|
6.15%
|
-
|
FCF Conversion (EBITDA)
|
67.06%
|
89%
|
-
|
-
|
34.58%
|
58.5%
|
52.24%
|
-
|
FCF Conversion (Net income)
|
99.55%
|
124.19%
|
-
|
-
|
9.17%
|
71.11%
|
61.98%
|
-
|
Dividend per Share
2 |
0.0230
|
0.0300
|
0.0367
|
0.0433
|
0.0500
|
0.0575
|
0.0688
|
0.0675
|
Announcement Date
|
2/19/20
|
2/25/21
|
2/23/22
|
2/22/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
107
|
179
|
158
|
372
|
206
|
221
|
247
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
52.5
|
69.6
|
-
|
-
|
36.5
|
67.8
|
65.3
|
-
|
ROE (net income / shareholders' equity)
|
13.5%
|
12.8%
|
12.2%
|
19%
|
53.9%
|
11.7%
|
12.6%
|
12.5%
|
ROA (Net income/ Total Assets)
|
9.78%
|
9.48%
|
9.13%
|
14.2%
|
10.2%
|
7.4%
|
8.3%
|
8.6%
|
Assets
1 |
539.4
|
591.2
|
650.5
|
712.7
|
3,891
|
1,288
|
1,269
|
1,296
|
Book Value Per Share
2 |
0.6000
|
0.6600
|
0.7100
|
0.7900
|
1.290
|
1.240
|
1.320
|
1.450
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
15.6
|
15.9
|
13.1
|
34.2
|
28.2
|
34.6
|
27.5
|
39.8
|
Capex / Sales
|
2.27%
|
2.27%
|
1.69%
|
3.9%
|
3.02%
|
3.46%
|
2.59%
|
3.46%
|
Announcement Date
|
2/19/20
|
2/25/21
|
2/23/22
|
2/22/23
|
2/21/24
|
-
|
-
|
-
|
Average target price
2.644
MYR Spread / Average Target -19.88% Consensus |
1st Jan change
|
Capi.
|
---|
| +32.53% | 497M | | +16.03% | 70.59B | | +2.22% | 25.06B | | +7.11% | 8.2B | | -2.98% | 7.92B | | -20.55% | 7.96B | | +3.42% | 4.71B | | +17.12% | 4.32B | | -1.24% | 4.01B | | -3.44% | 3.82B |
Pharmaceuticals Wholesale
|